ATE87216T1 - Polyvalentes hyperimmunglobulin-praeparat. - Google Patents

Polyvalentes hyperimmunglobulin-praeparat.

Info

Publication number
ATE87216T1
ATE87216T1 AT86105706T AT86105706T ATE87216T1 AT E87216 T1 ATE87216 T1 AT E87216T1 AT 86105706 T AT86105706 T AT 86105706T AT 86105706 T AT86105706 T AT 86105706T AT E87216 T1 ATE87216 T1 AT E87216T1
Authority
AT
Austria
Prior art keywords
hyperimmunoglobulin
polyvalent
preparative
antigen
gram
Prior art date
Application number
AT86105706T
Other languages
German (de)
English (en)
Inventor
Wolfgang Stephen
Herbert Dichtelmueller
Michael Kloft
Original Assignee
Biotest Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Pharma Gmbh filed Critical Biotest Pharma Gmbh
Application granted granted Critical
Publication of ATE87216T1 publication Critical patent/ATE87216T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/802—Antibody or antigen-binding fragment thereof that binds gram-positive bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/803—Antibody or antigen-binding fragment thereof that binds gram-negative bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/804—Drug, bio-affecting and body treating compositions involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT86105706T 1985-05-04 1986-04-25 Polyvalentes hyperimmunglobulin-praeparat. ATE87216T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853516119 DE3516119A1 (de) 1985-05-04 1985-05-04 Polyvalentes hyperimmunglobulin-praeparat
EP86105706A EP0201004B1 (de) 1985-05-04 1986-04-25 Polyvalentes Hyperimmunglobulin-Präparat

Publications (1)

Publication Number Publication Date
ATE87216T1 true ATE87216T1 (de) 1993-04-15

Family

ID=6269874

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86105706T ATE87216T1 (de) 1985-05-04 1986-04-25 Polyvalentes hyperimmunglobulin-praeparat.

Country Status (5)

Country Link
US (1) US4965068A (Direct)
EP (1) EP0201004B1 (Direct)
JP (1) JPH0667852B2 (Direct)
AT (1) ATE87216T1 (Direct)
DE (2) DE3516119A1 (Direct)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852950T2 (de) * 1988-12-22 1995-06-14 Baxter Diagnostics Inc Lipohaptene und Verwendung trägergebundener Lipohaptene im Immuntest.
US5093117A (en) * 1989-01-24 1992-03-03 Baxter International Inc. Compositions and method for the treatment or prophylaxis of sepsis or septic shock
EP0575517A1 (en) * 1991-03-15 1993-12-29 Univax Biologics Incorporated Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins
US5233024A (en) * 1991-04-09 1993-08-03 The Brigham & Women's Hospital Anti-idiotypic monoclonal antibodies for mucoid pseudomonas aeruginosa, their preparation and use
CA2153661A1 (en) * 1993-01-12 1994-07-21 Anthony George Gristina Methods and compositions for the direct concentrated delivery of passive immunity
RU2150960C1 (ru) * 1995-07-18 2000-06-20 Томский научно-исследовательский институт вакцин и сывороток НПО "Вирион" Способ получения иммуноглобулина противодифтерийного человека
ATE211486T1 (de) * 1995-09-22 2002-01-15 Zlb Bioplasma Ag Verfahren zur gewinnung von immunglobulinen aus fraktionen, die bei der fraktionierung von menschlichem blutplasma entstehen
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
NL1019143C2 (nl) * 2001-10-08 2003-04-09 Nutricia Nv Farmaceutisch product of voedingssupplement en daarbij te gebruiken tussenproduct.
WO2005077299A1 (en) * 2004-02-18 2005-08-25 Plasma Ventures Pty Ltd Isolated plasma and method for hyperimmunisation and plasma collection
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE14333C (de) * P. MAC LELLAN in Glasgow Gummimatte
BE791489A (fr) * 1971-11-17 1973-05-16 Max Planck Gesellschaft Agent immunisant, procede de fabrication et utilisation d'un tel agent
US4029762A (en) * 1971-11-17 1977-06-14 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Lipid A-preparation
US4174388A (en) * 1977-02-14 1979-11-13 Merck & Co., Inc. Method for preparing hepatitis B immune globulin
US4428931A (en) * 1982-03-15 1984-01-31 Merck & Co., Inc. Bacterial toxoids and gram-negative immune globulin therefrom
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin

Also Published As

Publication number Publication date
JPH0667852B2 (ja) 1994-08-31
EP0201004A2 (de) 1986-11-12
DE3688100D1 (de) 1993-04-29
DE3516119A1 (de) 1986-11-06
JPS6230729A (ja) 1987-02-09
DE3516119C2 (Direct) 1993-07-01
EP0201004B1 (de) 1993-03-24
US4965068A (en) 1990-10-23
EP0201004A3 (en) 1988-05-25

Similar Documents

Publication Publication Date Title
ATE87216T1 (de) Polyvalentes hyperimmunglobulin-praeparat.
NZ230148A (en) Ibd (infectious bursal disease) monoclonal antibody vaccines, immunised chicks and a method of assaying for ibd
AU8172094A (en) Synthetic HTLV-III peptides, compositions and uses thereof
NO864139D0 (no) Polypeptid virksomt ved dannelse av aids-antistoff.
NO175312C (no) Fremgangsmåte for rensing av et polypeptid med en del av den strukturelle oppbygning til blodplate-avledet vekstfaktor, samt monoklonalt antistoff som er spesifikt for en epitop derav
FI873553A7 (fi) HIV-infektioiden hoitoon ja diagnostisointiin käyttökelpoisia monoklonaalisia vasta-aineita ja peptidejä
IE940698L (en) Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
AU564575B2 (en) Polyvalent endotoxin specific antibodies
ES2179824T3 (es) Anticuerpos humanizados reactivos contra el antigeno gpiib/iiia.
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
AU584690B2 (en) E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
DK592086A (da) Humant conglutinin
DE3850993D1 (de) Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2.
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
WO1987006617A3 (en) Detection of a unique chlamydia strain associated with acute respiratory disease
Mehta et al. Neutralizing activity in isolated serum antibody fractions from visna-infected sheep
Moore et al. Characterization of Giardia lamblia trophozoite antigens using polyacrylamide gel electrophoresis, high-performance liquid chromatography, and enzyme-labeled immunosorbent assay
ATE75405T1 (de) Zeckenimpfstoff.
AU1626492A (en) Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
SE8703453D0 (sv) Preparation innehallande hogmolekylert bakteriellt protein, antikroppspreparation riktad deremot samt preparationernas anvendning
FI913530A0 (fi) Exkretoriska/sekretoriska bandmask -(cysticercus cellulosae)-antigener foer anvaendning i immunodiagnosis och vaccinationspreparat.
NO161274C (no) Fremgangsm te for fremstilling av immuninterferon.
Minster et al. Choice of the method for obtaining F(ab) sub (2)-fragments of human IgG for the determination of antibodies to staphylococcal protein A.
Moynihan STUDIES OF THE HUMAN V (, KAPPA IIIB) IMMUNOGLOBULIN LIGHT CHAIN SUB-SUBGROUP.
RU94038547A (ru) Способ получения иммуноглобулина для ингибиции иммунного ответа

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee